Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 63541

information corresponding to the 

isolates are submitted directly by the 

STD clinics to CDC. 

During 1986–2003, GISP 

demonstrated the ability to effectively 

achieve its objectives. The emergence, 

in the U.S., of resistance to 

fluoroquinolones, commonly used 

therapies for gonorrhea, was identified 

through GISP and makes ongoing 

surveillance critical. Emergence of 

decreased susceptibility to 

fluoroquinolones among the men having 

sex with men (MSM) population in the 

U.S. was also identified through GISP in 

2003. Data gathered through GISP were 

used to change the treatment for 

gonorrhea for the MSM population in 

April 2004. There are no costs to 

respondents other than their time. The 

estimated annualized burden for this 

data collection is 8,142 hours.

Respondent Number of

respondents 

Number of

responses 

per respondent 

Average

burden per

response

(in hours) 

Laboratory: 

Form 2 ........................................................................................................................................ 5 1368 1

Form 3 ........................................................................................................................................ 5 48 12/60

Clinical personnel .............................................................................................................................. 30 228 11/60

Dated: October 27, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24385 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Agency for Toxic Substances and 

Disease Registry 

Public Health Conference Support 

Grant Program 

Announcement Type: New. 

Funding Opportunity Number: 05002. 

Catalog of Federal Domestic 

Assistance Number: The Centers for 

Disease Control and Prevention (CDC) 

Catalog of Federal Domestic Assistance 

(CFDA) number is 93.283. The Agency 

for Toxic Substances and Disease 

Registry (ATSDR) Catalog of Federal 

Domestic Assistance (CFDA) number is 

93.161.

DATES: Key Dates:

Letter of Intent (LOI) Deadline: Cycle 

A: November 24, 2004; Cycle B: 

February 3, 2005. 

Application Deadline: Cycle A: 

January 14, 2005; Cycle B: April 6, 2005. 

I. Funding Opportunity Description

Authority: The Centers for Disease Control 

and Prevention (CDC) program is authorized 

under section 317(k)(2) of the Public Health 

Service Act, [42 U.S.C. 247b(k)(2)] as 

amended. The Agency for Toxic Substances 

and Disease Registry (ATSDR) program is 

authorized under sections 104 (i)(14) and (15) 

of the Comprehensive Environmental 

Response, Compensation, and Liability Act of 

1980 (CERCLA), as amended by the 

Superfund Amendments and Reauthorization 

Act of 1986 (SARA), [42 U.S.C. 9604(i)(14) 

and (15)].

Purpose: The Centers for Disease 

Control and Prevention (CDC) and the 

Agency for Toxic Substances and 

Disease Registry (ATSDR) announce the 

pending availability of appropriated 

fiscal year (FY) 2005 funds for a grant 

program for Public Health Conference 

Support. This program addresses the 

‘‘Healthy People 2010’’ focus areas of 

Disability and Secondary Conditions, 

Educational and Community-Based 

Programs, Environmental Health, Injury 

and Violence Prevention, Maternal, 

Infant and Child Health, Vision and 

Newborn Hearing (specifically newborn 

screening, evaluation and intervention), 

Public Health Infrastructure, 

Tuberculosis, Respiratory Diseases, and 

Sexually Transmitted Diseases (STD). 

Human Immunodeficiency Virus 

(HIV) Conferences and HIV subject 

matter are covered under another 

program and are not permitted under 

this announcement. 

The purpose of conference support 

funding is to provide partial support for 

specific non-Federal conferences (not a 

series) in the areas of health promotion 

and disease prevention information and 

education programs, and applied 

research. A series is the exact same 

conference conducted more than one 

time during the project period. An 

applicant can apply for funding for 

more than one different conference 

during the project period. 

Congress has required that there will 

be active participation by CDC/ATSDR 

in the development and approval of the 

conference agenda to make sure there 

are no subjects that would embarrass the 

Government or be an improper use of 

funds including portions that are not 

funded by CDC/ATSDR. CDC/ATSDR 

funds will be expended only for 

approved portions of the conference. 

The mission of CDC is to promote 

health and improve the quality of life by 

preventing and controlling disease, 

injury, and disability. 

Through the support of conferences 

and meetings (not a series) in the areas 

of public health research, education, 

prevention research in program and 

policy development in managed care 

and prevention application, CDC is 

meeting its overall goal of dissemination 

and implementation of new costeffective intervention strategies. 

The mission of ATSDR is to prevent 

both exposure and adverse human 

health effects that diminish the quality 

of life associated with exposure to 

hazardous substances from waste sites, 

unplanned releases, and other sources 

of pollution present in the environment. 

ATSDR’s systematic approaches are 

needed for linking applicable resources 

in public health with individuals and 

organizations involved in the practice of 

applying such research. Mechanisms are 

also needed to shorten the time frame 

between the development of disease 

prevention and health promotion 

techniques and their practical 

application. ATSDR believes that 

conferences and similar meetings (not a 

series) that permit individuals to engage 

in hazardous substances and 

environmental health research, 

education, and application (related to 

actual and/or potential human exposure 

to toxic substances) to interact, are 

critical for the development and 

implementation of effective programs to 

prevent adverse health effects from 

hazardous substances.

Measurable outcomes of the program 

will be in alignment with one (or more) 

of the following performance goal(s): 

Agency for Toxic Substances and 

Disease Registry (ATSDR): 

• Prevent ongoing and future 

exposures and resultant health effects 

from hazardous waste sites and releases; 

63542 Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 

• Determine human health effects 

associated with exposures to superfundrelated priority hazardous substances; 

• Mitigate the risks of human effects 

at toxic waste sites with documented 

exposures; 

• Build and enhance effective 

partnerships; 

• Promote effective and efficient 

agency management. 

National Center of Birth Defects and 

Developmental Disabilities (NCBDDD): 

• Increase the consumption of folic 

acid among women of reproductive age 

to prevent serious birth defects; 

• Decrease the number of women 

drinking during pregnancy; 

• Monitoring speech, language, and 

other developmental outcomes of 

infants with hearing loss; 

• Improve the data on the prevalence 

of birth defects and developmental 

disabilities; 

• Find causes and risk factors for 

birth defects and developmental 

disabilities in order to develop 

prevention strategies; 

• Monitor, characterize, and improve 

the health status of Americans with 

disabilities; 

• Increase knowledge by developing 

and implementing evidence-based 

approaches on adverse consequences of 

hereditary conditions including blood 

disorders. 

National Center for Environmental 

Health Services (NCEH): 

• Determine Human Health effects 

associated with environmental 

exposures and hazards; 

• Ensure laboratory standards are 

maintained in all certified labs for the 

following tests associated with health 

effects: Lipids, Newborn Screening, 

Blood Lead, and Urinary Iodine; 

• Ensure that 100 percent of chemical 

stockpiles housed at federal facilities are 

disposed of without any serious injuries 

or deaths from chemical agents; 

• Build and enhance effectively 

partnerships to improve environmental 

health capacity; 

• Provide assistance to 20 partners; 

• Promote effective and efficient 

NCEH management. 

National Center for (HIV), STD, and 

Tuberculosis (TB) Prevention 

(NCHSTP): 

• Strengthen the capacity of our STD, 

TB, and HIV prevention partners 

nationwide to monitor STD, TB, and 

HIV epidemic; 

• Develop and implement effective 

STD, TB, and HIV prevention 

interventions, and evaluate prevention 

programs. 

National Center for Injury Prevention 

and Control (NCIPC): 

• Reduce the risk of youth violence; 

• Reduce violence against women; 

• Enhance the capacity of states to 

implement effective rape prevention 

and education programs; 

• Reduce the number and severity of 

head injuries by increasing bicycle 

helmet use; 

• Improve the timelines and quality 

of data used to determine the medical 

and social impact of traumatic brain 

injury; 

• Reduce the incidence of residential 

fire-related injuries and deaths by 

increasing functional smoke alarms on 

every habitable floor; 

• Increase external input on the 

research priorities, policies, and 

procedures related to the extramural 

research supported by CDC; 

• Provide online access to injury 

prevention data; 

• Improve the uniformity, quality, 

and accessibility of emergency 

department data for public health 

surveillance in several states; ultimately 

developing the capacity to improve data 

in all states through development of 

guidelines, recommendations, or 

technical assistance. 

Public Health Practice Program Office 

(PHPPO): 

• Continue efforts to protect the 

safety and security of laboratorians 

regarding the handling and processing 

of biological agents; 

• Enhance the capacity (including 

laboratory) of CDC and state and local 

health departments to prepare for and 

respond to a biological and chemical 

terrorism event through rapid and 

accurate detection means, including the 

investigation and communication of 

critical information; 

• Continue efforts to protect the 

health and safety of first responders 

during biological and chemical 

terrorism events.

• Implement training programs to 

provide an effective workforce for U.S. 

health departments and laboratories and 

ministries of health in developing 

countries; 

• Ensure state and local health 

departments will monitor the health of 

its communities, and assist in the 

detection of emerging public health 

problems; 

• Conduct research to identify and 

evaluate community-based prevention 

interventions; 

• Strengthen the ability to obtain and 

disseminate extramural research 

findings to partners, public health 

practitioners, managed care 

organizations, and the public through a 

prevention research communications 

program; 

• Increase input from the external 

scientific community on extramural 

prevention research and strengthen the 

scope and nature of extramural public 

health research programs; 

• Disseminate research findings and 

other relevant information from 

prevention research programs to public 

health practitioners, managed-care 

organizations, and consumer groups; 

• Increase collaborations focusing on 

innovative intervention methods. 

This announcement is only for nonresearch activities supported by CDC/

ATSDR. If research is proposed, the 

application will not be reviewed. For 

the definition of research, please see the 

CDC Web site at the following Internet 

address: http://www.cdc.gov/od/ads/

opspoll1.htm.

Activities: In conducting activities to 

achieve the purpose of this program, the 

recipient will be responsible for the 

following activities: 

• The conference organizer(s) may 

use CDC’s/ATSDR’s name only in 

factual publicity for the conference. 

CDC/ATSDR involvement in the 

conference does not necessarily indicate 

support for the organizer’s general 

policies, activities, products, or the 

content of speakers’ presentations. 

• Any national conference cosponsored under this announcement 

shall be held in facilities that are fully 

accessible to the public as required by 

the Americans with Disabilities Act 

Accessibility Guidelines (ADAAG)(Does 

not apply to international conferences). 

Accessibility under ADAAG addresses 

accommodations for persons with 

sensory impairments as well as persons 

with physical disabilities or mobility 

limitations. 

• Manage all activities related to 

program content (e.g., objectives, topics, 

attendees, session design, workshops, 

special exhibits, speaker’s fees, agenda 

composition, and printing). Many of 

these items may be developed in concert 

with assigned CDC or ATSDR project 

personnel. 

• Provide draft copies of the agenda 

and proposed ancillary activities to CDC 

or ATSDR for approval. All but ten 

percent of the total funds awarded for 

the proposed conference will be initially 

restricted pending approval of a full, 

final agenda by CDC or ATSDR. The 

remaining 90 percent of funds will be 

released by letter to the grantee upon 

the approval of the final agenda. 

Because conference support by CDC and 

ATSDR creates the appearance of CDC 

co-sponsorship, there will be active 

participation by CDC or ATSDR in the 

development and approval of those 

portions of the agenda supported by 

CDC funds. CDC funds will not be 

expended for non-approved portions of 

meetings. In addition, CDC will reserve 

Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 63543

the right to approve or reject the content 

of the full agenda, press events, 

promotional materials (including press 

releases), speaker selection, and site 

selection. CDC and ATSDR reserve the 

right to terminate co-sponsorship if it 

does not concur with the final agenda. 

• Determine and manage all 

promotional activities (e.g., title, logo, 

announcements, mailers, press, etc.). 

CDC or ATSDR must review and 

approve any materials with reference to 

CDC or ATSDR involvement or support. 

• Manage all registration processes 

with participants, invitees, and 

registrants (e.g., travel, reservations, 

correspondence, conference materials 

and handouts, badges, registration 

procedures, etc.). 

• Plan, negotiate, and manage 

conference site arrangements, including 

all audio-visual needs. 

II. Award Information 

Type of Award: Grant. 

Fiscal Year Funds: FY 2005. 

Approximate Total Funding:

Approximately $600,000 may be 

available from CDC in FY 2005 to fund 

approximately 30 to 55 awards. 

Approximately $25,000 is available 

from ATSDR in FY 2005 to fund 

approximately three to five awards. 

Approximate Number of Awards: 60. 

Approximate Average of Awards: It is 

expected that the average award will be 

$20,000 for CDC and $8,000 for ATSDR. 

Floor of Award Range: None. 

Ceiling of Award Range: None. 

Anticipated Award Date: On or about 

sixty days before the date of the 

conference.

Budget Period Length: 12 month 

budget period for each cycle. 

Project Period Length: 12 month 

project period for each cycle. 

III. Eligibility Information 

III.1. Eligible Applicants 

Applications may be submitted for 

CDC support by public and private 

nonprofit organizations and by 

governments and their bona fide 

agencies, such as: 

• Public nonprofit organizations. 

• Private nonprofit organizations. 

• Faith-Based organizations. 

• Universities and Colleges. 

• Voluntary associations. 

• Foundations and civic groups. 

• Scientific or professional 

associations. 

• Federally recognized Indian tribal 

governments. 

Applications for ATSDR support in 

addition to the above may be submitted 

by the official public health agencies of 

the States or their bona fide agents. This 

includes: 

• The District of Columbia, the 

Commonwealth of Puerto Rico, the 

Virgin Islands, the Commonwealth of 

the Northern Marianna Islands, 

American Samoa, Guam, the Federated 

States of Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau. 

• Political subdivisions of States (in 

consultation with States). 

A bona fide agent is an agency/

organization identified by the state as 

eligible to submit an application under 

the state eligibility in lieu of a state 

application. If you are applying as a 

bona fide agent of a state or local 

government, you must provide a letter 

from the state or local government as 

documentation of your status. Place this 

documentation behind the first page of 

your application form. 

Also eligible are nationally and 

internationally recognized associations 

of health professionals and other 

chartered organizations generally 

recognized as demonstrating a need for 

information to protect the public from 

health effects of exposure to hazardous 

substances. 

Only conferences planned for May 1, 

2005 through September 30, 2006 are 

eligible to apply under this 

announcement. 

III.2 Cost Sharing or Matching 

Matching funds are not required for 

this program. 

III.3 Other 

CDC will accept and review 

applications with budgets greater than 

the ceiling of the award range. No 

ceiling limit has been established for 

Conference Support budgets. Refer to II 

Award Information for award ranges. 

Special Requirements 

• Late applications will be considered 

non-responsive. See section ‘‘IV.3. 

Submission Dates and Times’’ for more 

information on deadlines. 

• Applicants who do not submit a 

LOI will not be eligible to submit an 

application for review or funding. 

• Note: Title 2 of the United States 

Code Section 1611 states that an 

organization described in Section 

501(c)(4) of the Internal Revenue Code 

that engages in lobbying activities is not 

eligible to receive Federal funds 

constituting an award, grant, or loan. 

IV. Application and Submission 

Information 

IV.1. To Request Application Package 

To apply for this funding opportunity 

use application form PHS 5161–1 (OMB 

Number 0937–0189). Application forms 

and instructions are available on the 

CDC Web site, at the following Internet 

address: http://www.cdc.gov/od/pgo/

forminfo.htm.

If you do not have access to the 

Internet, or if you have difficulty 

accessing the forms on-line, you may 

contact the CDC Procurement and 

Grants Office Technical Information 

Management Section (PGO–TIM) staff 

at: 770–488–2700. Application forms 

can be mailed to you. 

IV.2. Content and Form of Submission 

Letter of Intent (LOI):

A Letter of Intent is required for this 

Program Announcement. The LOI will 

not be evaluated or scored. Your LOI 

will be used to estimate the potential 

reviewer workload and to avoid 

conflicts of interest during the review. 

You must submit an original and two 

copies. If you do not submit a LOI, you 

will not be allowed to submit an 

application. 

Your LOI must be written in the 

following format: 

• Maximum number of pages: two to 

three typewritten pages. 

• Font size: 12-point unreduced. 

• Single spaced. 

• Paper size: 8.5 by 11 inches. 

• Page margin size: One inch. 

• Printed only on one side of page. 

• Written in plain language, avoid 

jargon.

Your LOI must contain the following 

information: 

• The name of the organization. 

• Primary contact person’s name. 

• Mailing address. 

• Telephone number and, if available, 

fax and e-mail. 

• Title of the proposed conferenceinclude the term ‘‘conference,’’

‘‘symposium,’’ or similar designation. 

• Date(s) of conference-inclusive 

dates (not a series) of the conference. A 

series would be the exact same 

conference conducted more than one 

time. 

• Location of city, state, and physical 

facilities required for the conduct of the 

meeting. 

• Main Conference topics (no more 

than 2). See attachment II. 

• Total conference cost and total 

requested from CDC (must be less than 

100 percent). 

• Intended audience, approximate 

number, and profession of persons 

expected to attend. 

• Justification for the conference. 

This information must also be 

included in a summary page sent with 

the application. 

Application: You must submit a 

project narrative with your application 

forms. The narrative must be submitted 

in the following format: 

63544 Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 

• Maximum number of pages: 12 

pages. If your narrative exceeds the page 

limit, only the first pages, which are 

within the page limit, will be reviewed. 

• Font size: 12 point unreduced. 

• Double spaced. 

• Paper size: 8.5 by 11 inches. 

• Page margin size: One inch. 

• Printed only on one side of page. 

• Clearly numbered pages. 

• A complete index to the application 

and appendices. 

• Held together only by rubber bands 

or metal clips; not bound in any other 

way. 

Your narrative should address 

activities to be conducted during the 

entire project period: 

• A brief background of the 

organization—include the 

organizational history, purpose, and 

previous experience related to the 

proposed conference topic. 

• A clear statement of the need for 

and purpose of the conference. This 

statement should also describe any 

problems the conference will address or 

seek to solve, and the action items or 

resolutions it may stimulate. 

• An elaboration on the conference 

objectives and target audience. A list 

should be included of the principal 

areas or topics to be addressed. A 

proposed or final agenda must be 

included. 

• A clear description of the 

evaluation plan and how it will assess 

the accomplishments of the conference 

objectives. A sample of the evaluation 

instrument that will be used must be 

included and a step-by-step schedule 

and detailed operation plan of major 

conference planning activities necessary 

to attain specified objectives. 

• Budget plan and justification—A 

clearly justified budget narrative that is 

consistent with the purpose, objectives, 

and operation plan of the conference. It 

should include the share requested from 

this grant as well as those funds from 

other sources, including organizations, 

institutions, conference income, and/or 

registration fees. (The 12 page limit does 

not include the budget.) 

Additional information may be 

included in the application appendices. 

The appendices will not be counted 

toward the narrative page limit. This 

additional information includes: 

• Biographical sketches are required 

for the individuals responsible for 

planning and implementing the 

conference. Experience and training 

related to conference planning and 

implementation as it relates to the 

proposed topic should be noted. 

• Letters of endorsement or support—

Letters of endorsement or support for 

the sponsoring organization and its 

capability to perform the proposed 

conference activity. 

You are required to have a Dun and 

Bradstreet Data Universal Numbering 

System (DUNS) number to apply for a 

grant or cooperative agreement from the 

Federal government. The DUNS number 

is a nine-digit identification number, 

which uniquely identifies business 

entities. Obtaining a DUNS number is 

easy and there is no charge. To obtain 

a DUNS number, access 

www.dunandbradstreet.com or call 1–

866–705–5711. 

For more information, see the CDC 

Web site at: http://www.cdc.gov/od/pgo/

funding/pubcommt.htm.

Please include your DUNS number in 

your application cover letter. 

IV.3. Submission Dates and Times 

Deadline:

LOI and application deadlines have 

now been imposed for all conference 

support grants, and dates should be 

strictly followed by applicants to ensure 

that their LOIs and applications are 

received in a timely manner. There will 

be two conference support reviews this 

year. If your conference dates fall 

between May 1, 2005, to April 30, 2006, 

you should apply under Cycle A under 

this announcement. 

If your conference dates fall between 

August 1, 2005, to September 30, 2006, 

you should apply under Cycle B under 

this announcement. 

Letter of Intent Due Dates:

Cycle A: November 24, 2004. 

For conferences May 1, 2005–April 30, 

2006. 

Cycle B: February 3, 2005. 

For conferences August 1, 2005–

September 30, 2006. 

Letter of Intent (LOI) Submission:

On or before November 24, 2004, and 

February 3, 2005, submit an original and 

two signed copies of the LOI to: 

Technical Information Management 

PA#05002, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention, 2920 Brandywine Road, 

Atlanta, GA 30341–4146. 

Applicants who do not submit an LOI 

will not be eligible to submit an 

application for review or funding. 

Application Due Dates: Earliest 

Possible Award Dates:CYCLE A: January 

14, 2005, April 2005. CYCLE B: April 6, 

2005, June 2005. 

Submit application to:

Technical Information Management 

PA#05002, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention, 2920 Brandywine Road, 

Atlanta, GA 30341–4146. 

Applications may not be submitted 

electronically. Applications received 

that were not preceded by a LOI will not 

be reviewed or funded. 

Explanation of Deadlines: LOIs and 

Applications must be received in the 

CDC Procurement and Grants Office by 

4 p.m. Eastern Time on the deadline 

date. If you submit your LOI or 

application by the United States Postal 

Service or commercial delivery service, 

you must ensure that the carrier will be 

able to guarantee delivery by the closing 

date and time. If CDC receives your 

submission after closing due to: (1) 

Carrier error, when the carrier accepted 

the package with a guarantee for 

delivery by the closing date and time, or 

(2) significant weather delays or natural 

disasters, you will be given the 

opportunity to submit documentation of 

the carriers guarantee. If the 

documentation verifies a carrier 

problem, CDC will consider the 

submission as having been received by 

the deadline. 

This announcement is the definitive 

guide on LOI and application content, 

submission address, and deadline. It 

supersedes information provided in the 

application instructions. If your 

submission does not meet the deadline 

above, it will not be eligible for review, 

and will be discarded. You will be 

notified that you did not meet the 

submission requirements. 

CDC will not notify you upon receipt 

of your submission. If you have a 

question about the receipt of your LOI 

or application, first contact your courier. 

If you still have a question, contact the 

PGO–TIM staff at: 770–488–2700. Before 

calling, please wait two to three days 

after the submission deadline. This will 

allow time for submissions to be 

processed and logged.

IV.4. Intergovernmental Review of 

Applications 

Your application is subject to 

Intergovernmental Review of Federal 

Programs, as governed by Executive 

Order (EO) 12372. This order sets up a 

system for state and local governmental 

review of proposed federal assistance 

applications. You should contact your 

state single point of contact (SPOC) as 

early as possible to alert the SPOC to 

prospective applications, and to receive 

instructions on your state’s process. 

Click on the following link to get the 

current SPOC list: http://

www.whitehouse.gov/omb/grants/

spoc.html.

IV.5. Funding Restrictions 

Restrictions, which must be taken into 

account while writing your budget, are 

as follows: 

• Funds may be used for direct cost 

expenditures: Salaries; speaker fees (for

Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 63545

services rendered); rental of necessary 

conference—related equipment; 

registration fees; and transportation 

costs (not to exceed economy class fare) 

for non-Federal individuals. 

• Funds may be used for only those 

parts of the conference specifically 

supported by CDC or ATSDR as 

documented in the grant award. 

• Funds may not be used for the 

purchase of equipment; payments of 

honoraria (different from speaker fees in 

that it would be for someone to draw 

attention to the conference such as a 

celebrity and who usually has no 

expertise in the public health area); 

alterations or renovations; 

organizational dues; support 

entertainment or personal expenses; 

food or snack breaks; cost of travel and 

payment of a Federal employee or per 

diem or expenses for local participants 

(other than local mileage). Travel for 

Federal employees will be supported by 

CDC/ATSDR. Travel for other Federal 

employees will be supported by the 

employees’ Federal agency. 

• Funds may not be used for 

reimbursement of indirect costs. 

• CDC and ATSDR will not fund 100 

percent of any conference proposed 

under this announcement. Part of the 

cost of the proposed conference must be 

supported with funds other than Federal 

funds. 

• CDC and ATSDR will not fund a 

conference after it has taken place. 

• Federal funds may not be used to 

fund novelty items or souvenirs. 

Guidance for completing your budget 

can be found on the CDC Web site, at 

the following Internet address: http://

www.cdc.gov/od/pgo/funding/

budgetguide.htm.

IV.6. Other Submission Requirements 

LOI and Application Submission 

Address: Submit your original and two 

hard copies of LOI and application by 

express mail or delivery service to: 

Technical Information Management 

Section, PA 05002, Procurement and 

Grants Office, Centers for Disease 

Control and Prevention, 2920 

Brandywine Road, Room 3000, Atlanta, 

Georgia 30341–4146. LOIs and 

applications may not be submitted 

electronically at this time. 

V. Application Review Information 

V.1. Criteria 

Applicants are required to provide 

measures of effectiveness that will 

demonstrate the accomplishment of the 

various identified objectives of the 

grant. Measures of effectiveness must 

relate to the performance goals stated in 

the ‘‘Purpose’’ section of this 

announcement. Measures must be 

objective and quantitative, and must 

measure the intended outcome. These 

measures of effectiveness must be 

submitted with the application and will 

be an element of evaluation.

Each application will be evaluated 

individually against the following 

criteria by an independent review group 

appointed by CDC.

Section 1.a., is ATSDR specific 

Section 1.b., is CDC specific 

Section 1.c., and all other sections in 

these criteria are applicable to both 

CDC and ATSDR. Each application 

will be evaluated based on the 

following criteria: 

1. Proposed Program and Technical 

Approach (25 Points) 

a. The public health significance of 

the proposed conference, including the 

degree to which the conference can be 

expected to influence the prevention of 

exposure and adverse human health 

effects and diminished quality of life 

associated with exposure to hazardous 

substances from waste sites, unplanned 

releases and other sources of pollution 

present in the environment (Applicable 

to ATSDR applications only). 

b. The applicant’s description of the 

proposed conference as it relates to 

specific non-Federal conferences in the 

areas of health promotion and disease 

prevention information/education 

programs (except substance abuse), 

including the public health need of the 

proposed conference and the degree to 

which the conference can be expected to 

influence public health practices. 

Evaluation will also be based on the 

extent of the applicant’s collaboration 

with other organizations serving the 

intended audience (Applicable to all 

CDC applications except ATSDR). 

c. The applicant’s description of 

conference objectives in terms of 

quality, specificity, and the feasibility of 

the conference based on the operational 

plan will also be evaluated. 

2. Conference Objectives (25 Points) 

a. The overall quality, reasonableness, 

feasibility, and logic of the designed 

conference objectives, including the 

overall work plan and timetable are 

accomplished. 

b. The likelihood of accomplishing 

conference objectives as they relate to 

disease prevention and health 

promotion goals, and the feasibility of 

the project in terms of the operational 

plan. 

3. The Qualifications of Program 

Personnel (20 Points) 

Evaluation will be based on the extent 

to which the application has described: 

a. The extent to which the application 

provides evidence of the qualifications, 

experience, and commitment of the 

principal staff person, and his/her 

ability to devote adequate time and 

effort to provide effective leadership. 

b. The extent to which the application 

provides evidence of the competence of 

associate staff persons, discussion 

leaders, speakers, and presenters to 

accomplish conference objectives. 

c. The extent to which the application 

demonstrates the knowledge of 

nationwide and educational efforts 

currently underway which may affect, 

and be affected by, the proposed 

conference. 

4. Evaluation Methods (20 Points) 

Evaluation instrument(s) for the 

conference should adequately assess 

increased knowledge, attitudes, and 

behaviors of the target audience. 

5. Applicant’s Capability (10 Points) 

a. The applicant’s capability includes 

the adequacy of the applicant’s 

resources (additional sources of 

funding, organization’s strengths, staff 

time, proposed physical facilities, etc.) 

available for conducting conference 

activities. 

b. The extent to which the applicant 

demonstrates a history (at least three 

years) of managing conferences. 

6. Budget Justification and Adequacy of 

Facilities (Not Scored) 

The proposed budget will be 

evaluated on the basis of its 

reasonableness, concise and clear 

justification, and consistent with the 

intended use of grant funds. The 

application will also be reviewed as to 

the adequacy of existing or proposed 

facilities and resources for conducting 

conference activities. 

V.2. Review and Selection Process 

Applications will be reviewed for 

completeness by the Procurement and 

Grants Office (PGO) staff, and for 

responsiveness by the relevant CIO. 

Incomplete applications and 

applications that are non-responsive to 

the eligibility criteria will not advance 

through the review process. Applicants 

will be notified that their application 

did not meet submission requirements. 

An objective review panel consisting 

of CDC members outside the funding 

center will evaluate complete and 

responsive applications according to the 

criteria listed in the ‘‘V.1. Criteria’’

section above. Three reviewers from 

CDC staff that are not employees of the 

cognizant center will review and 

present their findings to the panel. The 

panel votes to approve or disapprove 

63546 Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 

based on this information and each 

application is scored and ranked. 

In addition, the following factors may 

affect the funding decision:

• Availability of funds 

• Relevance to program priorities. 

Applications will be funded in order 

by score and rank determined by the 

review panel. CDC/ATSDR will provide 

justification for any decision to fund out 

of rank order. 

V.3. Anticipated Announcement and 

Award Dates 

The anticipated announcement date is 

November 1, 2004 and the award dates 

will be 30–60 days before the 

conferences begin. 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will receive a 

Notice of Grant Award (NGA) from the 

CDC Procurement and Grants Office. 

The NGA shall be the only binding, 

authorizing document between the 

recipient and CDC. The NGA will be 

signed by an authorized Grants 

Management Officer, and mailed to the 

recipient fiscal officer identified in the 

application. 

Unsuccessful applicants will receive 

notification of the results of the 

application review by mail. 

VI.2. Administrative and National 

Policy Requirements 

45 CFR part 74 and part 92. 

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http://

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.

The following additional 

requirements apply to this project: 

• AR–7 Executive Order 12372. 

• AR–9 Paperwork Reduction Act 

Requirements. 

• AR–10 Smoke-Free Workplace 

Requirements. 

• AR–11 Healthy People 2010. 

• AR–12 Lobbying Restrictions. 

• AR–13 Prohibition on Use of CDC 

Funds for Certain Gun Control 

Activities. 

• AR–15 Proof of Non-Profit Status. 

• AR–20 Conference Support. 

Additional information on these 

requirements can be found on the CDC 

Web site at the following Internet 

address: http://www.cdc.gov/od/pgo/

funding/ARs.htm.

VI.3. Reporting Requirements 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report, due no less 

than 90 days before the end of the 

budget period. 

2. Financial status report, due no later 

than 90 days after the end of the budget 

period/project. 

These reports must be mailed to the 

Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, telephone: 770–488–2700. 

For program technical assistance, 

contact: Refer to the Attachment for 

contacts listed per each center. 

For business management assistance, 

contact: Edna Green, Grants 

Management Specialist, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone: 770–488–2743. e-mail: 

egreen@cdc.gov. 

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: http://www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: October 27, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

Attachment 

Topic Areas of Programmatic Interest and 

Contact Information 

100. Agency for Toxic Substances and 

Disease Registry (ATSDR)—LaShonda 

Billingsley, (404) 498–0275, 

LBillingsley@cdc.gov.

100.1 Health effects of hazardous 

substances in the environment; 

100.2 Disease and toxic substance exposure 

registries; 

100.3 Hazardous substance removal and 

remediation; 

100.4 Emergency Response to toxic and 

environmental disasters; 

100.5 Risk communication; 

100.6 Environmental Disease Surveillance; 

100.7 Investigation and research on 

hazardous substances in the environment 

300. National Center on Birth Defects and 

Developmental Disabilities (NCBDDD)—

Sheryl Heard, (404) 498–3978, 

SHeard@cdc.gov.

300.1 Birth Defects 

300.2 Fetal Alcohol Syndrome 

300.3 Disabilities: Issues related to people 

with disabilities; health promotion and 

intervention for persons with disabilities; 

secondary conditions; and aging and 

disability; 

300.4 Newborn and Childhood screening: 

Hearing, metabolic, genetic, and 

developmental 

300.5 Hearing Loss, early interventions, 

genetic causes 

300.6 Mental Retardation 

300.7 Child Development 

300.8 Autism Spectrum Disorders and 

Other Developmental Disabilities 

300.9 Hereditary Blood Disorders 

500. National Center for Environmental 

Health (NCEH)—LaShona Billingsley, (404) 

498–0275, LBillingsley@cdc.gov.

500.1 Genetics and Disease Prevention 

500.2 Emergency and Environmental Health 

Services (lead poisoning, environmental 

health hazards) 

500.3 Environmental Hazards and Health 

Effects (air pollution, asthma, health 

studies) 

500.4 Division of Laboratory Sciences (air 

toxins, newborn screening) 

600. National Center HIV, STD, and TB 

Prevention (NCHSTP)—Beth Wolfe, (404) 

639–8531, BWolfe@cdc.gov.

600.1 Sexually Transmitted Diseases (not 

HIV) 

600.2 Tuberculosis in Foreign Born Persons 

in the United States 

600.3 Tuberculosis in African American 

Populations in the United States 

(especially in the Southeast) 

600.4 Therapeutics and Diagnostics 

800.0 National Center for Injury Prevention 

and Control (NCIPC)—Benjamin Moore, 

(770) 488–4710, Moore@cdc.gov.

800.1 Unintentional Injuries Prevention 

800.2.1 National level conferences that 

focus on preventing child maltreatment 

before it occurs (primary prevention) 

800.2.2 National level conferences that 

focus on preventing youth violence before 

it occurs (primary prevention) 

800.3 Acute Injury Care 

800.4 Traumatic Brain Injury (TBI) 

800.5 Injury Related Disability 

800.6 Preparedness and Response for 

Injuries Resulting from Mass Causality 

Events and/or Terrorist Attacks 

800.7 Impact Biomechanics 

1500. Public Health Practice Program Office 

(PHPPO)—Janet Telman, (770) 488–2834, 

JTelman@cdc.gov.

1500.1 Laboratory Practice 

1500.2 Training and Materials

[FR Doc. 04–24390 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Task Force on Fetal Alcohol 

Syndrome and Fetal Alcohol Effect 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC)